Clinical Trial Update: Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant [Phase 4]

View source ↗

Summary

This Phase 4 trial update investigates changes in left ventricular mass and cardiac function in patients with active acromegaly who are treated with the growth …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Heart Failure
• Left Ventricular Hypertrophy

Drugs mentioned

• Somavert (pegvisomant)

Snippet

Sponsor: University of Wuerzburg | Conditions: Acromegaly, Heart Failure | Phase 4 | Status: UNKNOWN